Monique Gonzalez
Psychiatric/Mental Health · San Antonio, TXNPI 1699215293
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $81,388 of the $125,782 with a category attached, or 64.7%. Neurocrine Biosciences, Inc. accounts for 78.4% of it on its own, with 22 other manufacturers making up the rest. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 667 payments — averaging $188.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$99K
- AbbVie$16K
- Johnson & Johnson$2K
- Teva Pharmaceuticals USA, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $4K from 17 others
What the payments were for
- Consulting fees$20,33116%
- Speaking & faculty fees$81,38865%
- Travel & lodging$8,3107%
- Food & beverage$15,67412%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 181 | $98,574 |
| AbbVie | 101 | $16,397 |
| Johnson & Johnson | 59 | $2,359 |
| Teva Pharmaceuticals USA, Inc. | 82 | $2,028 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 69 | $1,370 |
| E.r. Squibb & Sons, L.L.C. | 7 | $1,308 |
| Otsuka America Pharmaceutical, Inc. | 40 | $674 |
| Vanda Pharmaceuticals Inc. | 26 | $670 |
| Axsome Therapeutics, Inc. | 7 | $441 |
| Sunovion Pharmaceuticals Inc. | 23 | $390 |
| Alkermes, Inc. | 17 | $365 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $313 |
| Lundbeck LLC | 13 | $233 |
| Eisai Inc. | 2 | $127 |
| Lilly USA, LLC | 1 | $114 |
| Sanofi | 1 | $112 |
| Merck | 6 | $88 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Noven Therapeutics, LLC | 2 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $35 |
| OWP Pharmaceuticals, Inc. | 2 | $32 |
| Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$125,782 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 22 | $148,882 |
| IngrezzaValbenazine Tosylate | 13 | $97,910 |
| CaplytaLumateperone Tosylate | 23 | $38,767 |
| TrintellixVortioxetine Hydrobromide | 37 | $19,955 |
| NuedextaDextromethorphan Hbr/Quinidine | 11 | $15,398 |
| Bupropion XlBupropion Hcl | 54 | $1,032 |
| Aripiprazole | 33 | $1,012 |
| Mirtazapine | 50 | $925 |
| Quetiapine Fumarate | 44 | $655 |
| Prazosin Hcl | 30 | $535 |
| Buspirone Hcl | 54 | $498 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $463 |
| Propranolol Hcl | 33 | $437 |
| Trazodone Hcl | 73 | $429 |
| Amitriptyline Hcl | 38 | $379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $2,028 | $148,88222 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $98,574 | $97,91013 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,370 | $38,76723 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $313 | $19,95537 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $35 | $15,39811 claims |
| Lilly USA, LLCOlanzapine | $114 | $30018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in San Antonio
- Geoffrey GonzalesSan Antonio$57K
- Sara Koenig LangstonSan Antonio$27K
- Peter TorciviaSan Antonio$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Marguerite AddisonWaco$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.